Picture of Syngene International logo

SYNGENE Syngene International Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Syngene International, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line4,1214,0493,9584,6445,100
Depreciation
Non-Cash Items1,0876871,6061,476500
Unusual Items
Other Non-Cash Items
Changes in Working Capital-630-469-2,855-1,550562
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities6,7717,0125,8068,23510,421
Capital Expenditures-6,431-4,465-4,755-5,183-5,108
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items2,147-1,816-1,360-1,381152
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-4,284-6,281-6,115-6,564-4,956
Financing Cash Flow Items-358-277-175-345-289
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2,255580-313-3,425-5,515
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2781,303-615-1,723-39